Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Similar articles for PubMed (Select 24803829)

1.

Association between esophageal cancer risk and EPHX1 polymorphisms: a meta-analysis.

Li QT, Kang W, Wang M, Yang J, Zuo Y, Zhang W, Su DK.

World J Gastroenterol. 2014 May 7;20(17):5124-30. doi: 10.3748/wjg.v20.i17.5124. Review.

2.

Lack of association between EPHX1 polymorphism and esophageal cancer risk: evidence from meta-analysis.

Yan YL, Chen X, Liang HJ, Wang J, Li TJ, Li RL, Li S, Qin X.

Dis Esophagus. 2015 Feb-Mar;28(2):164-71. doi: 10.1111/dote.12169. Epub 2014 Feb 20.

PMID:
25714851
3.

Association between microsomal epoxide hydrolase 1 polymorphisms and susceptibility to esophageal cancer: a meta-analysis.

Zhao W, Luo J, Cai X.

Tumour Biol. 2013 Aug;34(4):2383-8. doi: 10.1007/s13277-013-0787-y. Epub 2013 May 17.

PMID:
23681797
4.

Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk.

Liu F, Yuan D, Wei Y, Wang W, Yan L, Wen T, Xu M, Yang J, Li B.

PLoS One. 2012;7(8):e43821. doi: 10.1371/journal.pone.0043821. Epub 2012 Aug 23. Review.

5.

EPHX1 Tyr113His and His139Arg polymorphisms in esophageal cancer risk: a meta-analysis.

Tan X, He WW, Wang YY, Shi LJ, Chen MW.

Genet Mol Res. 2014 Jan 28;13(1):649-59. doi: 10.4238/2014.January.28.10.

6.

Role of epoxide hydrolase 1 gene polymorphisms in esophageal cancer in a high-risk area in India.

Ihsan R, Chattopadhyay I, Phukan R, Mishra AK, Purkayastha J, Sharma J, Zomawia E, Verma Y, Mahanta J, Saxena S, Kapur S.

J Gastroenterol Hepatol. 2010 Aug;25(8):1456-62. doi: 10.1111/j.1440-1746.2010.06354.x.

PMID:
20659238
7.

EPHX1 polymorphisms do not modify esophageal carcinoma susceptibility in Dutch Caucasians.

Dura P, Bregitha CV, Te Morsche RH, Roelofs HM, Kristinsson JO, Wobbes T, Witteman BJ, Tan AC, Drenth JP, Peters WH.

Oncol Rep. 2012 Jun;27(6):1710-6. doi: 10.3892/or.2012.1734. Epub 2012 Mar 19.

PMID:
22447130
8.

Meta-analysis demonstrates lack of an association of microsomal epoxide hydrolase 1 polymorphisms with esophageal cancer risk.

Hu JJ, Wang ZT, Li B.

Genet Mol Res. 2013 Oct 15;12(4):4540-8. doi: 10.4238/2013.October.15.2.

9.

System review and metaanalysis of the relationships between five metabolic gene polymorphisms and colorectal adenoma risk.

Zhao ZQ, Guan QK, Yang FY, Zhao P, Zhou B, Chen ZJ.

Tumour Biol. 2012 Apr;33(2):523-35. doi: 10.1007/s13277-011-0287-x. Epub 2011 Dec 13. Review.

PMID:
22161138
10.

Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer.

Jain M, Tilak AR, Upadhyay R, Kumar A, Mittal B.

Toxicol Appl Pharmacol. 2008 Jul 15;230(2):247-51. doi: 10.1016/j.taap.2008.02.023. Epub 2008 Mar 5.

PMID:
18406439
11.

Systematic Review and Meta-Analysis of the Relationship between EPHX1 Polymorphisms and the Risk of Head and Neck Cancer.

Chen H, Ge L, Sui Q, Lin M.

PLoS One. 2015 Apr 29;10(4):e0123347. doi: 10.1371/journal.pone.0123347. eCollection 2015.

12.

Try113His and His139Arg polymorphisms in the microsomal epoxide hydrolase gene are not associated with risk of breast cancer.

Gong WF, He W, Zhang QM, Xiang BD, Ma L, Huang S, Bai T, Zhong JH, Li LQ.

Tumour Biol. 2014 Aug;35(8):8087-93. doi: 10.1007/s13277-014-2084-9. Epub 2014 May 20.

PMID:
24840637
13.

Epoxide hydrolase Tyr113His polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma in population of North China.

Zhang JH, Jin X, Li Y, Wang R, Guo W, Wang N, Wen DG, Chen ZF, Kuang G, Wei LZ, Wang SJ.

World J Gastroenterol. 2003 Dec;9(12):2654-7.

14.

Quantitative assessment of the influence of EPHX1 gene polymorphisms and cancer risk: a meta-analysis with 94,213 subjects.

Yang X, Wang Y, Wang G.

J Exp Clin Cancer Res. 2014 Sep 28;33:82. doi: 10.1186/s13046-014-0082-9.

15.

Association between polymorphisms of microsomal epoxide hydrolase and COPD: results from meta-analyses.

Hu G, Shi Z, Hu J, Zou G, Peng G, Ran P.

Respirology. 2008 Nov;13(6):837-50. doi: 10.1111/j.1440-1843.2008.01356.x. Review.

PMID:
18811882
16.

XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies.

Ding DP, Ma WL, He XF, Zhang Y.

Mol Biol Rep. 2012 Mar;39(3):2533-40. doi: 10.1007/s11033-011-1005-x. Epub 2011 Jun 11.

PMID:
21667112
17.

Association between polymorphisms of EPHX1 and XRCC1 genes and the risk of childhood acute lymphoblastic leukemia.

Tumer TB, Sahin G, Arinç E.

Arch Toxicol. 2012 Mar;86(3):431-9. doi: 10.1007/s00204-011-0760-8. Epub 2011 Oct 9.

PMID:
21983886
18.

Lack of association of EPHX1 gene polymorphisms with risk of hepatocellular carcinoma: a meta-analysis.

Duan CY, Liu MY, Li SB, Ma KS, Bie P.

Tumour Biol. 2014 Jan;35(1):659-66. doi: 10.1007/s13277-013-1090-7. Epub 2013 Aug 17.

PMID:
23955801
19.

Meta-analysis of microsomal epoxide hydrolase gene polymorphism and the risk of breast carcinoma.

Zhong JH, Li LQ, Mo XS, Gong WF, Ma L, Chen J, You XM.

Genet Mol Res. 2015 Apr 27;14(2):4133-41. doi: 10.4238/2015.April.27.28.

20.

Pro variant of TP53 Arg72Pro contributes to esophageal squamous cell carcinoma risk: evidence from a meta-analysis.

Wang B, Wang D, Zhang D, Li A, Liu D, Liu H, Jin H.

Eur J Cancer Prev. 2010 Jul;19(4):299-307. doi: 10.1097/CEJ.0b013e32833964bc.

PMID:
20389250
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk